Cancers, Vol. 13, Pages 3698: Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors
Cancers, Vol. 13, Pages 3698: Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors
Cancers doi: 10.3390/cancers13153698
Authors:
Atsushi Makimoto
Jun Fang
Hiroshi Maeda
Most pediatric cancers are highly chemo-sensitive, and cytotoxic chemotherapy has always been the mainstay of treatment. Anthracyclines are highly effective against most types of childhood cancer, such as neuroblastoma, hepatoblastoma, nephroblastoma, rhabdomyosarcoma, Ewing sarcoma, and so forth. However, acute and chronic cardiotoxicity, one of the major disadvantages of anthracycline use, limits their utility and effectiveness. Hydroxypropyl acrylamide polymer-conjugated pirarubicin (P-THP), which targets tumor tissue highly selectively via the enhanced permeability and retention (EPR) effect, and secondarily releases active pirarubicin molecules quickly into the acidic environment surrounding the tumor. Although, the latter rarely occurs in the non-acidic environment surrounding normal tissue. This mechanism has the potential to minimize acute and chronic toxicities, including cardiotoxicity, as well as maximize the efficacy of chemotherapy through synergy with tumor-targeting accumulation of the active molecules and possible dose-escalation. Simply replacing doxorubicin with P-THP in a given regimen can improve outcomes in anthracycline-sensitive pediatric cancers with little risk of adverse e...
Source: Cancers - Category: Cancer & Oncology Authors: Atsushi Makimoto Jun Fang Hiroshi Maeda Tags: Review Source Type: research
More News: Bone Cancers | Brain | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Child Development | Childhood Cancer | Environmental Health | Ewing's Sarcoma | Heart | Hepatoblastoma | Neuroblastoma | Neurology | Pediatrics | Rhabdomyosarcoma | Sarcomas | Toxicology